These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 618993)

  • 41. Alpha 2-macroglobulin-kallikrein potentiates contact system activity: possible effect in asthma.
    Freyria AM; Lasser EC; Lyon SG; Simon RA
    Int Arch Allergy Appl Immunol; 1987; 83(4):341-7. PubMed ID: 2440813
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.
    Derkx FH; Bouma BN; Schalekamp MA
    J Lab Clin Med; 1984 Apr; 103(4):560-73. PubMed ID: 6366096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome.
    Kallen RJ; Lee SK
    Pediatr Res; 1975 Sep; 9(9):705-9. PubMed ID: 53808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purification of guinea-pig plasma prekallikrein. Activation by prekallikrein activator derived from guinea-pig skin.
    Yamamoto T; Kozono K; Okamoto T; Kato H; Kambara T
    Biochim Biophys Acta; 1980 Aug; 614(2):511-25. PubMed ID: 6967737
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1.
    Joseph K; Shibayama Y; Ghebrehiwet B; Kaplan AP
    Thromb Haemost; 2001 Jan; 85(1):119-24. PubMed ID: 11204562
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of surfaces on fluid-phase prekallikrein activation.
    Scott CF; Kirby EP; Schick PK; Colman RW
    Blood; 1981 Mar; 57(3):553-60. PubMed ID: 6906235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Diseases caused by kallikrein-kinin-system deficiencies].
    Ikari N; Kato H
    Nihon Rinsho; 1978 Aug; 36(8):2933-7. PubMed ID: 309519
    [No Abstract]   [Full Text] [Related]  

  • 48. Properties of sulfatides in factor-XII-dependent contact activation.
    Tans G; Griffin JH
    Blood; 1982 Jan; 59(1):69-75. PubMed ID: 6914902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel sensitive assay for functional factor XII based on the generation of kallikrein-C1-inhibitor complexes in factor XII-deficient plasma by glass-bound factor XII.
    Dors DM; Nuijens JH; Huijbregts CC; Hack CE
    Thromb Haemost; 1992 Jun; 67(6):644-8. PubMed ID: 1509403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prekallikrein activation in human, bovine, and rabbit plasmas: presence of an inhibitor in bovine plasma.
    Weerasinghe KM
    Inflammation; 1992 Jun; 16(3):205-13. PubMed ID: 1500097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of the kallikrein system in hyperbetalipoproteinemia.
    Carvalho AC; Lees RS; Vaillancourt RA; Cabral RB; Colman RW
    J Lab Clin Med; 1978 Jan; 91(1):117-22. PubMed ID: 201701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dose dependence of endotoxin-induced activation of the plasma contact system: an in vitro study.
    Roeise O; Bouma BN; Stadaas JO; Aasen AO
    Circ Shock; 1988 Dec; 26(4):419-30. PubMed ID: 2463883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dextran sulfate-dependent fibrinolysis in whole human plasma.
    Miles LA; Rothschild Z; Griffin JH
    J Lab Clin Med; 1983 Feb; 101(2):214-25. PubMed ID: 6185600
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kinin activation as a predictive assay for adverse reactions to radiographic contrast medium.
    Carr DH; Walker AC
    Acta Radiol Diagn (Stockh); 1984; 25(4):337-42. PubMed ID: 6567445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inositolphospholipid-accelerated activation of prekallikrein by activated factor XII and its inhibition by beta 2-glycoprotein I.
    Schousboe I
    Eur J Biochem; 1988 Oct; 176(3):629-36. PubMed ID: 2844532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoactivation of human plasma prekallikrein.
    Tans G; Rosing J; Berrettini M; Lämmle B; Griffin JH
    J Biol Chem; 1987 Aug; 262(23):11308-14. PubMed ID: 2440889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assay of Fletcher factor (plasma prekallikrein) using an artificial clotting reagent and a modified chromogenic assay.
    Soulier JP; Gozin D
    Thromb Haemost; 1979 Aug; 42(2):538-47. PubMed ID: 505362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prekallikrein activation, C1 esterase inhibitor, and factor XII as predictors of adverse reaction to contrast media. A prospective study.
    Hagan JJ; Yost FJ; Nickoloff EL
    Invest Radiol; 1987 Jun; 22(6):490-4. PubMed ID: 3497903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kallikrein-kinin system in the plasma of snakes.
    Picarelli ZP; Prezoto BC; Hiraichi E; Abdalla FM
    Agents Actions Suppl; 1992; 36():271-81. PubMed ID: 1609651
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of heparin on the activation of factor XII and the contact system in plasma.
    Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
    Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.